⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNSE News
Sensei Biotherapeutics, Inc. Common Stock
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
ATOS
ONCY
SNSE
TNGX
OSTX
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
ATOS
ONCY
SNSE
TNGX
OSTX
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SNSE
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
SNSE
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
globenewswire.com
SNSE
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
SNSE
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
globenewswire.com
SNSE